View Older Stories View More Recent Stories

Sep 12, 2018 04:30PM Clearside Biomedical Appoints Viral Kansara as Vice President, Discovery
Sep 12, 2018 04:30PM Clearside Biomedical Appoints Viral Kansara as Vice President, Discovery
Sep 11, 2018 01:38AM Alcon picks Geneva over Texas for new HQ
Sep 11, 2018 01:00AM Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis
Sep 6, 2018 05:10AM Novartis unloads U.S. assets at loss to bargain-hunting Aurobindo
Aug 29, 2018 08:58AM Pre-Open Movers 08/29: (GKOS) (TLRY) (SPHS) (EXPR) Higher; (AEO) (DKS) (ROKU) Lower
Aug 29, 2018 07:44AM Glaukos Corporation (GKOS) Gains After Alcon (NVS) Announces Withdrawal of CyPass Micro-Stent from Market
Aug 29, 2018 01:00AM Alcon announces voluntary global market withdrawal of CyPass Micro-Stent for surgical glaucoma
Aug 20, 2018 06:30AM Aerie Pharmaceuticals Announces Appointment of Jeffrey White, Ph.D. as Director, Toxicology and Pharmacokinetics
Jul 31, 2018 04:31AM MerLion Regains North American Rights to XTOROTM FDA-Approved Antibiotic for Treatment of Ear Infections
Jul 20, 2018 09:05AM Alcon introduces NGENUITY® 3D Visualization System with DATAFUSION™ to simplify, customize vitreoretinal surgery
Jul 18, 2018 07:59AM Novartis (NVS) Tops Q2 EPS by 2c (Earlier)
Jul 18, 2018 04:20AM Novartis hints at 2018 outlook hike despite drug price freeze
Jul 18, 2018 01:00AM Novartis delivers solid growth in second quarter and continues transformation to a focused medicines company
Jul 17, 2018 08:00AM Sinovant Sciences, Company Focused on the Development of Innovative Medicines in China, Unveiled at Event in Beijing
Jun 30, 2018 05:55AM Novartis chairman says Alcon worth $20 billion-$30 billion: Finanz und Wirtschaft
Jun 29, 2018 08:44AM Novartis (NVS) to Spinoff Alcon (Earlier)
Jun 29, 2018 01:23AM Novartis hands investors Alcon spin-off, $5 billion share buyback
Jun 29, 2018 01:00AM Novartis announces intention to seek shareholder approval for 100% spinoff of Alcon eye care devices business; initiates share buyback of up to USD 5 bn
Jun 27, 2018 08:00AM uStudio Introduces First Secure Podcast Solution for Private Enterprise Communications
Jun 18, 2018 01:15AM Novartis International AG: Alcon AcrySof® IQ PanOptix® trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery
May 22, 2018 11:01AM Earth Science Laboratories Expands Research and Development
May 17, 2018 08:45AM Alcon teams up with Venus Williams, tennis champion and dry eye sufferer, to launch Systane® Complete eye drops
May 16, 2018 01:23AM Novartis top lawyer exits over Trump attorney deal 'mistake'
May 16, 2018 01:15AM At the Meet Novartis Management investor event, Novartis highlights strategy to focus the company and drive sustainable growth
May 9, 2018 04:47AM UBS poaches investment banker Illy from Credit Suisse
May 7, 2018 01:15AM Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
May 7, 2018 01:15AM Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
May 1, 2018 04:25PM Alcon Introduces AIR OPTIX® COLORS Contact Lenses Gemstone Collection, Creating New Ways to Enhance and Play with Eye Color
May 1, 2018 09:00AM ViewPoint Appoints Dr. Robert Kim as Chief Medical Officer
Apr 23, 2018 02:00AM Lysogene Strengthens Board of Directors with Appointment of Dr. Peter Lichtlen
Apr 23, 2018 02:00AM Lysogene Strengthens Board of Directors with Appointment of Dr. Peter Lichtlen
Apr 19, 2018 07:10AM Novartis (NVS) Misses Q1 EPS by 1c, Revenue Beats
Apr 19, 2018 04:02AM Novartis CEO feels heat on U.S. generics, Cosentyx drop
Apr 19, 2018 01:00AM Novartis delivered a strong first quarter and acted to become a more focused medicines company
Apr 13, 2018 04:15PM Alcon introduces pre-loaded delivery system for the CyPass® Micro-Stent to enhance surgical experience
Apr 3, 2018 08:00AM New Review of Dry Eye Disease - Current Insights and Future Perspectives - touchOPHTHALMOLOGY
Apr 3, 2018 07:15AM New Review of Early Clinical Experiences with Brinzolamide/Brimonidine Fixed Combination in Open-angle Glaucoma and Ocular Hypertension - touchOPHTHALMOLOGY
Apr 3, 2018 07:00AM New Review of Modern Perspectives on Dry Eye Disease - touchOPHTHALMOLOGY
Mar 28, 2018 02:45PM Hoodoo Digital Brings Next Generation Media Capabilities to Adobe Experience Manager
Mar 27, 2018 01:12AM GSK buys out Novartis in $13 billion consumer healthcare shake-up
Mar 15, 2018 12:41PM ThromboGenics Business Update - FY 2017
Mar 15, 2018 12:40PM ThromboGenics Business Update - FY 2017
Mar 15, 2018 11:30AM Back of the Eye Disorders, Featuring a Steadily Growing Pipeline, Likely to Witness 7.9% Annualized Growth, Predicts Roots Analysis
Feb 21, 2018 10:29AM Greek parliament to probe politicians in alleged Novartis bribe case
Feb 15, 2018 09:00AM uStudio Expands Enterprise Portfolio
Feb 8, 2018 03:20AM 2017 Annual Results
Feb 5, 2018 06:09PM Performance Health Appoints Jeff George as Chief Executive Officer
Jan 25, 2018 07:19AM Novartis (NVS) PT Raised to $100 at Leerink Partners
Jan 24, 2018 01:00AM Novartis delivered good operational performance and landmark innovation in 2017, entering our next growth phase
View More Recent Stories View Older Stories